Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2015-07-10 Interim / Quarterly Rep…
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT JANUARY-JUNE 2015' and contains comprehensive financial statements, including the consolidated income statement, statement of comprehensive income, statement of financial position, and statement of changes in equity. It provides detailed analysis of financial performance, business operations, and risks for the specified period. It is not a short announcement or a certification, but the full interim report itself, fitting the definition of an Interim/Quarterly Report (IR). H2 2015
2015-07-10 English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I KARO BIO
AGM Information Classification · 99% confidence The document is titled "KALLELSE TILL EXTRA BOLAGSSTÄMMA I KARO BIO" which translates to 'NOTICE TO AN EXTRAORDINARY GENERAL MEETING IN KARO BIO'. It details the date, time, location, shareholder registration requirements, and the proposed agenda for an Extraordinary General Meeting (EGM). The agenda includes significant corporate actions like a directed new share issue, amendment of the articles of association, a share consolidation (1:20 reverse split), and a capital reduction. This document is a formal notice calling shareholders to vote on these matters, which strongly aligns with the purpose of an Annual General Meeting (AGM) notice, even though it is an 'Extra' meeting. The closest classification among the provided options is AGM-R (AGM Information), as it pertains to the formal meeting process and materials presented for shareholder vote, which is the core function of an AGM/EGM notice.
2015-07-07 Swedish
Nyemissionen i Karo Bio övertecknad
Share Issue/Capital Change Classification · 98% confidence The document is a press release dated June 24, 2015, announcing the successful completion and oversubscription of a rights issue (nyemission) for Karo Bio. It details the number of shares issued, the total capital raised (around 230 mkr), the utilization of the over-allotment option, and the resulting increase in the total number of shares and share capital. This content directly relates to fundraising, financing activities, and capital structure changes. Based on the definitions: - It is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). - It is specifically about a capital raise/financing activity. - The most fitting category is 'Capital/Financing Update' (CAP). - It is not a general regulatory filing (RNS) because it fits a specific category. - It is not a Share Issue announcement (SHA) in the sense of a stock split or general share change, but rather a specific financing event (rights issue) which falls under CAP.
2015-06-24 Swedish
KARO BIO OFFENTLIGGÖR PROSPEKT GÄLLANDE FÖRETRÄDESEMISSIONEN
Report Publication Announcement Classification · 99% confidence The document is a press release titled "KARO BIO OFFENTLIGGÖR PROSPEKT GÄLLANDE FÖRETRÄDESEMISSIONEN" (Karo Bio publishes prospectus regarding the rights issue). It explicitly states that the prospectus has been approved and registered by the Swedish Financial Supervisory Authority (Finansinspektionen) and that the invitation to subscribe for shares will only occur through this published prospectus. Since the document's primary function is to announce the publication of a formal offering document (the prospectus) related to a capital action (rights issue), it fits best under the category for financing activities or capital structure changes. The most fitting code among the options is 'CAP' (Capital/Financing Update), as a rights issue is a core financing activity. Although it announces a document, the content is focused on the financing event itself rather than just the announcement of a report's availability (RPA/RNS). Given the context of a rights issue prospectus publication, CAP is the most specific fit.
2015-06-02 Swedish
Ändring av antalet aktier och röster i Karo Bio AB (publ)
Share Issue/Capital Change Classification · 98% confidence The document is a short announcement (1173 characters) in Swedish regarding a change in the total number of shares and votes for Karo Bio AB. It explicitly states the new total count (689,743,550 shares) and attributes the increase to an acquisition and a directed share issue. This directly relates to a change in the company's capital structure or share count. The most fitting category is 'Share Issue/Capital Change' (SHA). It is not a general regulatory filing (RNS) because it fits a specific category, and it is not an announcement of a report (RPA) because it contains the core information itself.
2015-05-29 Swedish
Change of the number of shares and votes in Karo Bio AB (publ)
Share Issue/Capital Change Classification · 98% confidence The document is a short press release announcing a change in the total number of outstanding shares and votes due to a recent acquisition and a directed new share issue. This directly relates to a change in the company's capital structure. Based on the definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate classification, as it covers changes in the number of shares. It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a financing update (CAP) which usually implies fundraising activities, although it is related to capital structure.
2015-05-29 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.